NIH Seeks Comments on Mental Health Archive
Published Date: 6/3/2026
Notice
Summary
The National Institute of Mental Health (NIMH) is asking for a 30-day public comment period to review and approve their data collection process for the Mental Health Data Archive. This affects researchers and anyone who shares mental health data with NIMH. Comments are due by June 3, 2026, and there’s no new cost involved—just keeping things clear and up-to-date!
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Researchers' 90‑Minute Data Forms
If you are a researcher who submits data to or requests access from the NIMH Data Archive (NDA), you must complete either a Data Submission Agreement (DSA) or a Data Use Certification (DUC). Each response takes about 90 minutes; there are an estimated 300 submitting researchers and 950 access-requesting researchers, for a total annualized burden of 1,875 hours. There are no monetary costs to respondents, OMB approval is requested for 3 years, the current control expires 2026-06-30, and comments are due by June 3, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
Previous / Next Documents
Previous: 2026-11043, Initiation of Section 301 Investigation and Request for Public Comments: Vietnam's Acts, Policies, and Practices Related to Intellectual Property Protection and Enforcement
The U.S. is launching an investigation into Vietnam for not protecting intellectual property rights fairly, which affects American businesses relying on these protections. This could lead to changes in trade rules or penalties if Vietnam doesn’t improve. Public comments are open until July 2, 2026, so anyone interested can share their thoughts before decisions are made.
Next: 2026-11046, Vanda Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Refuse To Approve a Supplemental New Drug Application for HETLIOZ (Tasimelteon)
Vanda Pharmaceuticals asked the FDA to approve a new use for their sleep drug HETLIOZ to treat jet lag, but the FDA said no and now there’s a public hearing to decide what’s next. This affects Vanda, travelers hoping for a jet lag fix, and could delay the drug’s availability while money and time are on the line. The hearing starts July 20, 2026, so mark your calendars!